Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


MannKind reported $356.73M in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Eli Lilly LLY:US USD 18.88B 4.14B
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Insmed INSM:US USD 1.16B 6.32M
Karyopharm Therapeutics KPTI:US USD 303.02M 201K
MannKind MNKD:US USD 356.73M 11.27M
Novavax NVAX:US USD 197.85M 146K
Novo Nordisk A Fs NVO:US DKK 24.27B 51M
Peregrine Pharmaceuticals PPHM:US USD 142.06M 129K